Saturday, October 31, 2026
Data from SEC filings, checked daily
Public filings, plainly told
Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
Data updated Oct 31, 2026·New filings added every weekday·Weekly prices as of Oct 2·What changed·
Insider tradingForm 4

Vanda Pharmaceuticals Inc. (VNDA) Insider Trading

6 open-market trades reported since Feb 24, 2026: 0 purchases worth $0 and 6 sales worth $2.82M.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Mihael Hristos PolymeropoulosCEO0$01$1.28MMar 4, 2026
Kevin Patrick MoranCFO0$01$351KMar 4, 2026
Timothy WilliamsGeneral Counsel0$01$351KMar 4, 2026
Gunther BirznieksSVP0$01$351KMar 4, 2026
Joakim WijkstromSVP0$01$255KMar 4, 2026
Tage HonoreDirector0$01$241KFeb 24, 2026

All trades

VNDA insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHolding3 mo. afterFiling
Mar 4Mar 2Mihael Hristos PolymeropoulosCEOCEO▼ SELL156,2358.17$1.28M−5.5%Form 4 ↗
Mar 4Mar 2Kevin Patrick MoranCFOCFO▼ SELL42,4428.27$351K−9.4%Form 4 ↗
Mar 4Mar 2Timothy WilliamsGeneral CounselGeneral Counsel▼ SELL42,4348.27$351K−10%Form 4 ↗
Mar 4Mar 2Gunther BirznieksSVPSVP▼ SELL42,4318.27$351K−7.9%Form 4 ↗
Mar 4Mar 2Joakim WijkstromSVPSVP▼ SELL30,8008.27$255K−8.5%Form 4 ↗
Feb 24Feb 23Tage HonoreDirectorDirector▼ SELL30,0008.03$241K−24%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 31, 2026. How we read filings

Report an error

Tell us what looks wrong on this page. We check every report against the original filing and fix mistakes on our corrections page.

Share this trade
XTelegram
My Desk · free

Sign in to follow

Follow stocks, members of Congress, famous investors and funds, and see what's new each time you come back.